For about a month, Professor Bülent Tutluoğlu, a Pulmonologist with Acıbadem Healthcare Group, was battling COVID-19 in the intensive care unit, with a 50% chance of recovery. Over the course of treatment, he was intubated and placed on plasmapheresis or ‘cleaning’ of blood and stem cell therapy. Yet all he could think of was getting back to his patients.
Professor Tutluoğlu was one of the first few physicians who were infected by COVID-19 in Turkey several days after the country recorded its first case on 11 March. He was admitted to the hospital on 17 March, where he was eventually tested COVID-19 positive.
As his condition worsened, he was transferred to the intensive care unit, where he was put on ventilation and started on a challenging treatment involving plasmapheresis and stem cell therapy.
While I was anaesthetised by my colleagues at the intensive care unit, I told myself that I cannot be defeated by this infection,” said the Professor.
After battling the disease for almost a month, he was finally well to go home. As he walked out of the ward, cheered on by well-wishers, his first response when asked what he was looking forward to most, was: “I can go back to treating my patients now!”
Related Stories
.jpg?sfvrsn=21d67f46_1)
IHH Singapore Collaborates with Insurers to Improve Affordability of Private Hospital Care
Taking Preventive Health to New Heights at The IHH Sky Race | Merdeka 118
IHH Healthcare Malaysia highlights Care. For Good. through its role as title partner and official medical provider of The IHH Sky Race | Merdeka
Gleneagles Hospital Hong Kong Highlights Healthcare at ITB China 2026
Travel today is no longer defined by destinations alone — it is shaped by the confidence and assurance travellers carry with them.
IHH Malaysia Strengthens Care Integration Through GP-Specialist Collaboration
A referral is more than an appointment with another doctor, it is an act of trust.
Parkway MediCentre Xintiandi Launches Integrated Chinese and Western Medicine Health Management Services
Themed "Echoes of the World, Pulse of China", Parkway MediCentre Xintiandi showcased the role of Traditional Chinese Medicine (TCM) through an integrated healthcare approach.
Fortis Memorial Research Institute (FMRI) Launches India's First Centre of Excellence for Myeloma and Lymphoma
Officiated on 11 June, the FMRI Centre of Excellence, brings a highly specialised, patient‑centred and research‑driven approach to managing blood cancers.
